Low Risk of Treatment Failure after Substitution of Nevirapine for Protease Inhibitors among Human Immunodeficiency Virus-Infected Patients with Virus Suppression

There is little information about the risk of treatment failure after a switch from human immunodeficiency virus (HIV) protease inhibitors (PIs) to nevirapine (Nvp) for patients with successful virus suppression. This study compared the 1-year risk of treatment failure for patients switching from a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of infectious diseases 2002-05, Vol.185 (9), p.1261-1268
Hauptverfasser:	Dieleman, Jeanne P., Sturkenboom, Miriam C.J.M., Wit, Ferdinand W., Jambroes, Marielle, Mulder, Jan-Willem, ten Veen, Jacob H., Juttmann, Job, Stricker, Bruno H.C., Lange, Joep M.A., van der Ende, Marchina E.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult AIDS Antibiotics. Antiinfectious agents. Antiparasitic agents Antiretroviral Therapy, Highly Active Antiretrovirals Antiviral agents Biological and medical sciences CD4 Lymphocyte Count Cohort Studies Female Highly active antiretroviral therapy HIV HIV 1 HIV Infections - drug therapy HIV Infections - immunology HIV Infections - virology HIV Protease Inhibitors - therapeutic use Human immunodeficiency virus Human viral diseases Humans Infectious diseases Major Articles Male Medical sciences Medical treatment failures Memory interference Middle Aged Nevirapine - adverse effects Nevirapine - therapeutic use Pharmacology. Drug treatments Risk RNA RNA, Viral - blood Treatment Failure Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids Virology Viruses
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!